Last reviewed · How we verify
Jinshuibao Capsule
Jinshuibao Capsule is a traditional Chinese medicine formulation that enhances renal blood perfusion and protects kidney function through multi-component herbal synergy.
Jinshuibao Capsule is a traditional Chinese medicine formulation that enhances renal blood perfusion and protects kidney function through multi-component herbal synergy. Used for Chronic kidney disease, Diabetic nephropathy, IgA nephropathy.
At a glance
| Generic name | Jinshuibao Capsule |
|---|---|
| Also known as | Jinshuibao Jiaonang, Cordyceps sinensis, Artificial Cordyceps sinensis powder, basic treatment |
| Sponsor | Second Xiangya Hospital of Central South University |
| Drug class | Traditional Chinese Medicine (TCM) herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
Mechanism of action
The capsule combines multiple herbal ingredients traditionally used in Chinese medicine to improve microcirculation in the kidneys, reduce proteinuria, and slow the progression of chronic kidney disease. It is believed to work through anti-inflammatory and antioxidant mechanisms while supporting renal hemodynamics and glomerular filtration.
Approved indications
- Chronic kidney disease
- Diabetic nephropathy
- IgA nephropathy
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease (PHASE2, PHASE3)
- Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Jinshuibao Capsule CI brief — competitive landscape report
- Jinshuibao Capsule updates RSS · CI watch RSS
- Second Xiangya Hospital of Central South University portfolio CI